BRAF and melanoma: In a previous work, with the aim to verify whether Ole might potentiate drug efficiency on BRAF mutant melanoma cells, we decided to use a non-toxic 250 μM dose able to reduce cell proliferation rate without affecting cancer cell viability and apoptosis.